MedTrace Logo

Telemedicine in High-Risk Cardiovascular Patients Post-ACS

NCT05015634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 337

Last updated 2026-03-17

Study results available
· View outcomes & findings →

Summary

This is a non-CTIMP randomised controlled trial looking at the utilisation of telemedicine devices to provide remote, clinically necessary, diagnostic information, without the need for hospital attendance that patients will take home with them following admission to hospital with a heart attack.

Conditions

Interventions

OTHER

Active Arm

Patient develops possible cardiac symptoms, takes an ECG, BP and oxygen saturation as per their training. Patient will receive a phone call by the trial cardiologist who will have access to a high-quality ECG trace, as well as blood pressure and oxygen saturations, and coupled with the clinical history, can decide on the most appropriate course of further management. With remote follow up over the phone at 3, 6 and 9 months.

OTHER

Control Arm

Standard routine clinical care will be carried out, with remote follow up over the phone at 3, 6 and 9 months.

Sponsors & Collaborators

  • King Khalid University

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Ramzi Y Khamis, MB ChB PhD FRCP · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-06
Primary Completion
2025-02-28
Completion
2025-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05015634 on ClinicalTrials.gov